Survival benefits

Recent randomised controlled trials have shown survival benefits of months, when PRO tools are  implemented in cancer care. At the root of gaining these benefits is the paradigm shift from reactive to proactive care that is enabled trough PRO usage.

More specifically, the survival benefits of PRO tools result from:
Early and systematic recognition of severe symptoms and relapses. As threatening conditions are recognised early on, they can be treated while before they turn into severe, even deadly complications.

Enhanced toxicity management. When health care personnel gets information on the patient on a daily or weekly basis, toxicities can be observed and managed in real time. Reducing toxicity improves treatment outcomes.

Better dosage optimisation. As systematic information on the patient’s condition is obtained, better decisions on the medication can be made.

Optimal treatment duration. Research shows that when PRO tools are used, patients stay in chemotherapy longer and better treatment outcomes are seen.

Improved functionality of patients - This results from better symptom management and better QoL obtained trough PRO’s

 

Costs of care

Proactive treatment management trough PRO’s has shown to decrease hospitalisation and ER visits, which have a big impact on the costs of care.  This results from symptoms and side-effects being treated early before they turn into severe complications, as well as from better symptom management.

PRO usage aids in reducing the workload of health care professionals. As patients communicate with the clinic trough PRO tools, it becomes easier to manage the work, and less phone calls are received. This gives an opportunity to focus on the patients who need more support, and mild symptoms may be treated by giving self-care instructions or automated interventions.

PRO’s also makes clinicians work more efficient. As a holistic report with the most important details is received  before a visit, they get a view on the patient’s condition with one glimpse.

The need for timely discussions is reduced, and clinicians can directly focus on the symptoms that the patients have b been experiencing.